Hasvold; Lisa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hasvold; Lisa.The latest application filed is for "bromodomain inhibitors".

Company Profile

3.13.25

Hasvold; Lisa - Grayslake IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bromodomain Inhibitors App 20210236508 - Wang; Le ; et al.	2021-08-05
Bromodomain Inhibitors App 20210130346 - Hardee; David ; et al.	2021-05-06
Bromodomain Inhibitors App 20210047304 - Cowart; Marlon ; et al.	2021-02-18
Bromodomain Inhibitors App 20190382383 - Cowart; Marlon ; et al.	2019-12-19
Bromodomain Inhibitors App 20190084981 - Dai; Yujia ; et al.	2019-03-21
Bromodomain inhibitors Grant 10,131,657 - Dai , et al. November 20, 2	2018-11-20
Bromodomain Inhibitors App 20180296566 - Wang; Le ; et al.	2018-10-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180251426 - Bruncko; Milan ; et al.	2018-09-06
Bromodomain inhibitors Grant 9,957,263 - Dai , et al. May 1, 2	2018-05-01
Bromodomain Inhibitors App 20160272630 - Dai; Yujia ; et al.	2016-09-22
Bromodomain Inhibitors App 20160185769 - Dai; Yujia ; et al.	2016-06-30
Bromodomain Inhibitors App 20160143916 - Wang; Le ; et al.	2016-05-26
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,315,488 - Ding , et al. April 19, 2	2016-04-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,303,025 - Bruncko , et al. April 5, 2	2016-04-05
Bromodomain inhibitors Grant 9,296,741 - Wang , et al. March 29, 2	2016-03-29
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20160009687 - Ding; Hong ; et al.	2016-01-14
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2	2015-09-08
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2	2015-07-07
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,073,855 - Doherty , et al. July 7, 2	2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150183775 - BRUNCKO; Milan ; et al.	2015-07-02
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,045,420 - Doherty , et al. June 2, 2	2015-06-02
Bromodomain Inhibitors App 20140162971 - WANG; Le ; et al.	2014-06-12
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ; et al.	2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ; et al.	2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ; et al.	2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ; et al.	2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ; et al.	2014-02-27
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,586,754 - Bruncko , et al. November 19, 2	2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20130296295 - BRUNCKO; Milan ; et al.	2013-11-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,563,735 - Bruncko , et al. October 22, 2	2013-10-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20120190688 - Bruncko; Milan ; et al.	2012-07-26
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100305122 - Bruncko; Milan ; et al.	2010-12-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100298323 - Bruncko; Milan ; et al.	2010-11-25
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100298321 - Bruncko; Milan ; et al.	2010-11-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100160322 - Bruncko; Milan ; et al.	2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100152183 - Bruncko; Milan ; et al.	2010-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.